Head-to-head · Value Score
Alan Meds vs bmiMD
Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, bmiMD a 89. Here's who gives you the honest lower price — and where each one bites back.
Alan Meds
#5 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-namebmiMD
#8 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameThe verdict
Alan Meds takes it on Value Score, 90 to 89 — an est. $99/mo first month, with no teaser step-up baked in. bmiMD isn't out of it: Price-first shoppers who want the cheapest tier on both molecules from a nationwide program.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Alan Meds | bmiMD |
|---|---|---|
| Value Score | 90 (A) | 89 (A) |
| Est. first month | $99/mo | $99/mo |
| Save vs brand-name | ~93% | ~93% |
| Semaglutide | $99/mo | $99/mo |
| Tirzepatide | $145/mo | $139/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Alan Meds
Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.
Why it's a deal
- $99 flat semaglutide and a low $145 tirzepatide
- Available in all 50 states
- Offers an oral/sublingual route
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Newer operator with a thin public track record
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.